Somatostatin in the central nervous system: physiology and pathological modifications.
about
Cloning and characterization of a fourth human somatostatin receptorBiochemical and functional properties of somatostatin receptorsSynthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2Identification of multiple somatostatin receptors in the rat somatosensory cortex during developmentSomatostatin Depresses the Excitability of Subicular Bursting Cells: Roles of Inward Rectifier K+ Channels, KCNQ channels and Epac.Presence of a plasma membrane targeting sequence in the amino-terminal region of the rat somatostatin receptor 3.Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis.Purification of a putative brain somatostatin receptor.Regulation of ATP-sensitive K+ channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP.The somatostatinergic system in the mammalian cochlea.Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neuronsAntiangiogenic effects of somatostatin analogues.Calcitonin gene-related peptides and neuromuscular interactions.Somatostatin receptors in the gastrointestinal tract in health and diseaseCSF galanin and cognition after shunt surgery in normal pressure hydrocephalusSomatostatinergic systems: an update on brain functions in normal and pathological aging.Activity-regulated somatostatin expression reduces dendritic spine density and lowers excitatory synaptic transmission via postsynaptic somatostatin receptor 4.Expression of the somatostatin subtype 2A receptor in the rabbit retina.Development of antibodies against the rat brain somatostatin receptor.Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity.Somatostatin potentiates the alpha 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate.Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.Expression of functional pituitary somatostatin receptors in Xenopus oocytes.Anticonvulsant neuropeptides as drug leads for neurological diseases.Somatostatin analogs for the treatment of neuroendocrine tumors.Hypothalamus as an endocrine organ.Identification of a functional 3',5'-cyclic adenosine monophosphate response element within the second promoter of the mouse somatostatin receptor type 2 gene.Transcriptomic identification of starfish neuropeptide precursors yields new insights into neuropeptide evolutionProduction of peptides as generic drugs: a patent landscape of octreotide.Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i).Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes.Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells.Pancreatic beta-cell somatostatin receptors.Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.
P2860
Q24563011-FAE1FC0B-AF9C-48B2-888A-8F2D77032C52Q28210100-57995E8A-9818-464F-A6A4-2275A461556DQ28368778-B08667A3-0533-40AF-97FC-8CF95B97B062Q28570904-ED8E564A-60B4-47A6-BD3C-78933961C390Q30101028-32DCB480-61D7-4199-884A-AF328A8A5585Q30830407-EE5B36FD-EC09-4486-8820-D336747EBE22Q33785713-28D2E622-CB15-4F66-9096-630A5BCF064CQ33839527-5E5B1FD4-C571-4B69-BD9C-4F07C95812FBQ33851631-FD0713C4-BD14-405D-9D6B-E6409F56B45CQ34012292-E44EED03-60B7-4AC8-863D-F21CC3524191Q34132339-8D89EA7B-C758-4BE9-8A35-CE4D32ACBB83Q34324349-EE576614-5CFF-4942-8CC2-07B5EE061D0FQ34920676-5A60AB6A-637B-41BD-BEC9-48DC2816F135Q35230797-9524F662-EBF9-42C8-BEAB-E687B0798170Q35241625-7F4C536D-1B23-48D8-8F90-EAB6A71BFBAFQ35476661-D7388AA9-4017-4C44-AE26-1FB6A412D815Q36449496-8D5F07B9-771F-49C8-B6C2-3C6565A1DDD8Q36562017-D808DB64-A843-40C9-A1F4-45B12173C872Q36964979-C6FB4C05-5109-450C-8A38-5E0141B3AC47Q37002466-B3A22008-CEAA-488D-9EDB-42C8A8D937BBQ37155476-95D7FBE5-3B1F-4614-8F18-0E27464A5297Q37246839-2DE67B3C-CC0D-460F-B8D0-C5981EEC7112Q37604466-89D581C2-C7BB-4D25-B084-2AAB68058F4AQ37619163-5555A019-9B02-4EEB-AA44-BDFBED0D62B7Q37660052-5CA2EDF1-56E9-4E64-A278-383AE8DF165FQ37845684-4F40797F-1924-4B89-9DE9-1A666F36C3E6Q37849210-8A78037E-7B8F-43D9-ACAA-797B180B28C5Q38318629-F980C184-249E-4EEE-9201-94778EFDF2B6Q38330243-88562D09-5C19-4BF0-9415-43F3958F49FFQ38697129-C17F11E8-1F59-420C-9C1B-15CCA7700B3DQ38754043-90F1CC61-D9E0-46A8-A9CA-E48AB6E4AF86Q39590527-3A7318DF-2E36-49ED-B835-200005BD95E9Q39645788-EA1DFEC4-56D7-4748-93D3-572EF6B78330Q40469120-8B7A51A0-DF26-43CB-BB9E-90FB02731FEEQ40642381-8960DCBF-0BA6-4728-BB4E-BE7F672BAC37Q41107460-62063C80-61C9-4056-B1B2-A591CA7CE481Q41233319-0E3ADBA2-2A00-405C-9383-07BA43E2EC0FQ41455281-04B21D1B-8505-41A5-B65F-2294A47E6B0FQ41727285-126BF665-7071-4245-92A7-64E82ED3CDCBQ41824623-F91E88F0-8AF9-4E2D-B213-BCCEA5658589
P2860
Somatostatin in the central nervous system: physiology and pathological modifications.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Somatostatin in the central nervous system: physiology and pathological modifications.
@en
Somatostatin in the central nervous system: physiology and pathological modifications.
@nl
type
label
Somatostatin in the central nervous system: physiology and pathological modifications.
@en
Somatostatin in the central nervous system: physiology and pathological modifications.
@nl
prefLabel
Somatostatin in the central nervous system: physiology and pathological modifications.
@en
Somatostatin in the central nervous system: physiology and pathological modifications.
@nl
P1476
Somatostatin in the central nervous system: physiology and pathological modifications.
@en
P2093
Epelbaum J
P304
P356
10.1016/0301-0082(86)90012-2
P577
1986-01-01T00:00:00Z